Øivind Foss
Chief Tech/Sci/R&D Officer at ULTIMOVACS ASA
Profile
Øivind Foss is currently the Head of Clinical Operations at Ultimovacs ASA. Prior to this, he worked as the Director of Clinical Project Management at Smerud Medical Research International AS and as the Director of Clinical Operations at Pharmalink Oncology AS.
Foss holds a doctorate degree from the Norwegian University of Science & Technology.
Øivind Foss active positions
Companies | Position | Start |
---|---|---|
ULTIMOVACS ASA | Chief Tech/Sci/R&D Officer | - |
Former positions of Øivind Foss
Companies | Position | End |
---|---|---|
Pharmalink Oncology AS | Chief Tech/Sci/R&D Officer | - |
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Training of Øivind Foss
Norwegian University of Science & Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Private companies | 2 |
---|---|
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Health Technology |
Pharmalink Oncology AS |
- Stock Market
- Insiders
- Øivind Foss